| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.008 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |